Cookies on the
NIAA website

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies may have already been set. You can delete and block the cookies but this may impair the functionality of the website. To find out more about the cookies, please see our privacy policy.

2009 Round 2 - AAGBI/Anaesthesia Small Research Grant

Dr Vimal Grover
Dr Vimal Grover

Dr Vimal Grover

Clinical Fellow in Intensive Care Medicine & Anaesthetics SpR (Imperial School) Chelsea and Westminster Hospital

The use of soluble and surface TREM-1 (Triggering Receptor Expressed on Myeloid cells) as a marker of Ventilator Associated Pneumonia (VAP) in Intensive Care

Summary: Our study sought to speed up the diagnosis of VAP and differentiate it from non-pulmonary infection by measurement of an immune protein (TREM-1) in bronchoalveolar lavage (BAL) fluid and blood. TREM-1 levels were measured on CD14 positive monocytes in ventilated patients with VAP and non-pulmonary sepsis as well as ventilated and non-ventilated non-infected controls.

BAL monocytic surface TREM-1 increased in VAP. The BAL/blood ratio increased discrimination further between the groups and differentiated sites of infection. A biomarker panel incorporating this ratio and other proteins showed promise in diagnosing VAP.